Viewing Study NCT00209924



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00209924
Status: COMPLETED
Last Update Posted: 2007-03-30
First Post: 2005-09-13

Brief Title: A Study of Gaboxadol in Primary Insomnia
Sponsor: H Lundbeck AS
Organization: H Lundbeck AS

Study Overview

Official Title: A Prospective Randomised Double-Blind Parallel-Group Placebo-Controlled Study of Gaboxadol in Primary Insomnia
Status: COMPLETED
Status Verified Date: 2007-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia
Detailed Description: To compare hypnotic efficacy of gaboxadol with placebo in elderly outpatients with primary insomnia

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None